I agree Denner not the right pick to replace Glickman. However, what I like about Glickman is his charisma and ability to connect with the audience he addresses, whether that be scientific or financial conference. with that said Denner's, homeboy, Paris P would be a great option. Currently I don't think he is a CEO, tho serves on the Medicines Co board of directors with Sarissa Folks , I think he is an Operating Partner at Clarus and EC of Genevant at the moment